ReviewClinical reviews in allergy & immunology2011
Therapeutic perspectives in atopic dermatitis.
Review in Clinical reviews in allergy & immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 29 citations in OpenAlex.
- Impressic Acid Ameliorates Atopic Dermatitis-Like Skin Lesions by Inhibiting ERK1/2-Mediated Phosphorylation of NF-κB and STAT1.International journal of molecular sciences · 2021Article
- Non-thermal plasma inhibits mast cell activation and ameliorates allergic skin inflammatory diseases in NC/Nga mice.Scientific reports · 2019Article
- Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses.Scientific reports · 2019Article
- Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro.British journal of pharmacology · 2018Article
- Oral Aspects Identified in Atopic Dermatitis Patients: A Literature Review.The open dentistry journal · 2018Review
- Beneficial effects of melittin on ovalbumin-induced atopic dermatitis in mouse.Scientific reports · 2017Article
- Interferons: Success in anti-viral immunotherapy.Cytokine & growth factor reviews · 2014Review
- Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis.Cell death & disease · 2014Article
- Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial.Allergy, asthma & immunology research · 2014Article
- Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.Clinical reviews in allergy & immunology · 2013Review
- The practical understanding and treatment of asthma.Clinical reviews in allergy & immunology · 2012Article
- Atopic dermatitis: new trends and perspectives.Clinical reviews in allergy & immunology · 2011Review
- Novel challenges for the allergist.Clinical reviews in allergy & immunology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Therapy of atopic dermatitis should comprise emollients, topical glucocorticosteroids, or calcineurin inhibitors, phototherapies, immunosuppressants like cyclosporin A, and other treatments. All these treatments should be improved, thanks to research. But new therapeutic perspectives should be given by topical anti-inflammatory substances, selective glucocorticoid receptor agonists, probiotics, interferon γ, TNFα inhibitors, inhibition of T cells or B cells, inhibition of IgE binding, and many other possibilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.